BONE BIOLOGICS CORPORATION
Income Statement
| Line Item | FY2020 | FY2019 |
|---|---|---|
| Revenue | $1.07B | $1.07B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $340.7K | $1.1M |
| SG&A Expense | $484.3K | $1.4M |
| Operating Income | $-825.0K | $-2.4M |
| Operating Margin | -0.1% | -0.2% |
| Interest Expense | — | — |
| Pretax Income | $-1.8M | $-3.4M |
| Income Tax Expense | $1.6K | $1.6K |
| Net Income | $-1.8M | $-3.4M |
| Net Margin | -0.2% | -0.3% |
| EPS (Basic) | $-0.02 | $-0.02 |
| EPS (Diluted) | $-0.02 | $-0.02 |
| Shares Outstanding (Basic) | 368.2M | 920.5M |
| Shares Outstanding (Diluted) | 368.2M | 920.5M |
| Dividends Per Share | — | — |